IL6 and inflammatory bowel disease: Possible mechanisms underlying the increased risk for cardiovascular disorders in patients with IBD have been proposed such as increased levels of inflammatory cytokines (i.e., tumor necrosis factor-α (TNF-α), interleukin-1β, (IL-1β), IL-6), oxidative stress, hypercoagulability, decreased numbers of circulating endothelial progenitor cells, and endothelial dysfunction [9,25,36,37,38].